Because dietary factors, lifestyle and environmental factors are known to affect p53 function in hepatoma cancer (aflatoxin B and hepatitis B [133,134,135,136]) and in lung and oesophageal cancer (due to tobacco use [88,137]), it is highly likely that infection and tobacco use could precipitate TP53 mutations in EC too. Here, TP53 is linked to hepatitis B virus infection.